3-85912522-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001167675.2(CADM2):āc.679A>Gā(p.Met227Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,436 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001167675.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CADM2 | NM_001167675.2 | c.679A>G | p.Met227Val | missense_variant | 6/10 | ENST00000383699.8 | NP_001161147.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CADM2 | ENST00000383699.8 | c.679A>G | p.Met227Val | missense_variant | 6/10 | 1 | NM_001167675.2 | ENSP00000373200.3 | ||
CADM2 | ENST00000405615.2 | c.658A>G | p.Met220Val | missense_variant | 5/10 | 1 | ENSP00000384193.2 | |||
CADM2 | ENST00000407528.6 | c.652A>G | p.Met218Val | missense_variant | 5/10 | 1 | ENSP00000384575.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250580Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135424
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461436Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727030
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2024 | The c.658A>G (p.M220V) alteration is located in exon 5 (coding exon 5) of the CADM2 gene. This alteration results from a A to G substitution at nucleotide position 658, causing the methionine (M) at amino acid position 220 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at